Cosmetic firms already are at risk of being sued following an FDA warning letter for overreaching product claims, but a pending decision from the U.S. Supreme Court could incentivize litigation against companies even in instances where FDA has been silent regarding their marketing.
Athena Cosmetics, Inc. awaits the Supreme Court's decision on its request for a hearing following lower court rulings that determined...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?